Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Advanced hydrogel-based drug delivery systems for psoriasis management: From material design to multi-target therapies.

Created on 13 Jul 2026

Authors

Huijuan Liang, Huina Cao, Shulin Pu, Runqi Xu, YaQi Xu, Chengxiao Wang

Published in

International journal of pharmaceutics: X. Volume 12. Pages 100599. Epub Jul 04, 2026.

Abstract

Psoriasis is a chronic inflammatory skin disorder driven by the interplay of genetic, immunological, and environmental factors. Hydrogels, featuring excellent biocompatibility and tunable structures, have emerged as pivotal platforms for topical psoriasis management. Although existing studies have explored hydrogel drug delivery and sustained release, they often remain confined to single-target interventions or basic formulations. This review updates recent advances by elucidating intervention mechanisms from the pathological microenvironment. We highlight synergistic strategies using smart hydrogels and nanogels, with emphasis on their core strengths in sustained/controlled release, enhanced penetration, and dosage form design. Finally, future perspectives and targeted strategies are proposed to address critical bottlenecks in clinical translation, including manufacturing standards and long-term safety. This work aims to provide theoretical guidance for developing next-generation hydrogel formulations with high efficacy and low toxicity.

PMID:
42438664
Bibliographic data and abstract were imported from PubMed on 13 Jul 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 3
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement